94
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Successful Pregnancy after Cladribine Therapy for Hairy Cell Leukemia

Pages 187-188 | Received 03 May 2003, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Beatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, Gayane Melikyan, Faiza Ibrahim & Yolande Hanssens. (2020) Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations. Journal of Drug Assessment 9:1, pages 20-36.
Read now
Clara G. Chisari, Simona Toscano, Emanuele D’Amico, Salvatore Lo Fermo, Aurora Zanghì, Sebastiano Arena, Mario Zappia & Francesco Patti. (2019) An update on the safety of treating relapsing-remitting multiple sclerosis. Expert Opinion on Drug Safety 18:10, pages 925-948.
Read now
Tamar Tadmor. (2011) Purine analog toxicity in patients with hairy cell leukemia. Leukemia & Lymphoma 52:sup2, pages 38-42.
Read now

Articles from other publishers (14)

Benjamin Meir Jacobs, Francesca Ammoscato, Gavin Giovannoni, David Baker & Klaus Schmierer. (2018) Cladribine: mechanisms and mysteries in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 89:12, pages 1266-1271.
Crossref
Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks, Alessandro Finkelsztejn, Paulo Diniz da Gama, Anderson K. Grzesiuk, Vanessa Daccach Marques, Monica Fiuza K. Parolin, Henry K. Sato, Daniel Lima Varela & Claudia Cristina F. Vasconcelos. (2018) Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurology and Therapy 7:2, pages 207-232.
Crossref
L S Al-radi, T N Moiseeva, S Yu Smirnova & R G Shmakov. (2017) Hairy cell leukemia and pregnancy. Terapevticheskii arkhiv 89:7, pages 99-104.
Crossref
T. Robak, E. Matutes, D. Catovsky, P.L. Zinzani & C. Buske. (2015) Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 26, pages v100-v107.
Crossref
Stéphane Barete, Olivier LortholaryGandhi DamajIsabelle HirschMarie Olivia ChandesrisCaroline ElieMohamed HamidouIsabelle DurieuFelipe SuarezBernard GrosboisNicolas LimalEmmanuel GyanClaire LarrocheGérard GuilletJean Emmanuel KahnPhilippe CasassusKarima AmazzoughHélène Coignard-BiehlerSophie Georgin-LavialleLudovic LhermitteSylvie FraitagDanielle CanioniPatrice DubreuilOlivier Hermine. (2015) Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis. Blood 126:8, pages 1009-1016.
Crossref
Ewelina Wawryk-Gawda, Patrycja Chylińska-Wrzos, Marta Lis-Sochocka, Kamila Bulak & Barbara Jodłowska-Jędrych. (2014) Intrinsic Apoptosis Pathway in Fallopian Tube Epithelial Cells Induced by Cladribine. The Scientific World Journal 2014, pages 1-9.
Crossref
Bruce AC Cree. (2013) Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Multiple Sclerosis Journal 19:7, pages 835-843.
Crossref
Naval Daver, Aziz Nazha, Hagop M. Kantarjian, Rodney Haltom & Farhad Ravandi. (2013) Treatment of Hairy Cell Leukemia During Pregnancy: Are Purine Analogues and Rituximab Viable Therapeutic Options. Clinical Lymphoma Myeloma and Leukemia 13:1, pages 86-89.
Crossref
Teri L. SchreinerAugusto Miravalle. (2012) Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine. Journal of Central Nervous System Disease 4, pages JCNSD.S5128.
Crossref
Karen Schreiber & Per Soelberg Sorensen. (2011) Cladribine in the treatment of multiple sclerosis. Clinical Investigation 1:2, pages 317-326.
Crossref
Thomas P. Leist & Robert Weissert. (2011) Cladribine. Clinical Neuropharmacology 34:1, pages 28-35.
Crossref
Hans-Peter Hartung, Orhan Aktas, Bernd Kieseier & Giancarlo Comi. (2009) Development of oral cladribine for the treatment of multiple sclerosis. Journal of Neurology 257:2, pages 163-170.
Crossref
H.-P. Hartung, B.C. Kieseier & O. Aktas. (2010) CladribinCladribin. Der Nervenarzt 81:2, pages 194-202.
Crossref
George Pentheroudakis & Nicholas Pavlidis. (2006) Cancer and pregnancy: Poena magna, not anymore. European Journal of Cancer 42:2, pages 126-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.